Cargando…

Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis

Aortic valve stenosis is the most common valvular heart disease in the Western world. Lipoprotein(a) (Lp(a)) is an independent risk factor of coronary heart disease (CHD) and calcific aortic valve stenosis (CAVS). The aim of this study was to assess the role of Lp(a) and its autoantibodies [autoAbs]...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burdeynaya, Anna L., Afanasieva, Olga I., Ezhov, Marat V., Klesareva, Elena A., Saidova, Marina A., Pokrovsky, Sergey N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047835/ https://www.ncbi.nlm.nih.gov/pubmed/36975592 http://dx.doi.org/10.3390/diseases11010043

Ejemplares similares

Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level
por: Afanasieva, Olga, et al.
Publicado: (2020)

Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis
por: Chubykina, Uliana V., et al.
Publicado: (2022)

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease
por: Tmoyan, Narek A., et al.
Publicado: (2021)

Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease
por: Afanasieva, Olga I., et al.
Publicado: (2022)

Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease
por: Afanasieva, Olga I., et al.
Publicado: (2023)

Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries
por: Ezhov, Marat V., et al.
Publicado: (2021)

The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis
por: Afanasieva, Olga I., et al.
Publicado: (2021)

Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels
por: Ezhov, Marat, et al.
Publicado: (2019)

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction
por: Afanasieva, Olga I., et al.
Publicado: (2022)

Lipoprotein(a) as Orchestrator of Calcific Aortic Valve Stenosis
por: Schnitzler, Johan G., et al.
Publicado: (2019)

The Concentration of PCSK9-Lp(a) Complexes and the Level of Blood Monocytes in Males with Coronary Atherosclerosis
por: Filatova, Anastasiia Yu., et al.
Publicado: (2023)

Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve Stenosis
por: Bourgeois, Raphaëlle, et al.
Publicado: (2020)

Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis
por: Zheng, Kang H., et al.
Publicado: (2019)

Cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosis
por: Kocyigit, Duygu, et al.
Publicado: (2021)

Lipoprotein(a): Its Association with Calcific Aortic Valve Stenosis, the Emerging RNA-Related Treatments and the Hope for a New Era in “Treating” Aortic Valve Calcification
por: Tsamoulis, Donatos, et al.
Publicado: (2023)

Lipoprotein(a)-Associated Molecules Are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis
por: Torzewski, Michael, et al.
Publicado: (2017)

Celecoxib Is Associated With Dystrophic Calcification and Aortic Valve Stenosis
por: Bowler, Meghan A., et al.
Publicado: (2019)

Autotaxin and Lipoprotein Metabolism in Calcific Aortic Valve Disease
por: Mathieu, Patrick, et al.
Publicado: (2019)

Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
por: Kaiser, Yannick, et al.
Publicado: (2022)

Role for Galectin‐3 in Calcific Aortic Valve Stenosis
por: Sádaba, J. Rafael, et al.
Publicado: (2016)

Antiphospholipid antibodies in patients with calcific aortic valve stenosis
por: Plunde, Oscar, et al.
Publicado: (2022)

Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis
por: Thomassen, Henrik K, et al.
Publicado: (2017)

Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification( )
por: Kaiser, Yannick, et al.
Publicado: (2022)

Hyperlipoproteinemia(a) and Severe Coronary Artery Lesion Types
por: Ilina, Larisa N., et al.
Publicado: (2022)

Valve Calcification in Aortic Stenosis: Etiology and Diagnostic Imaging Techniques
por: Izquierdo-Gómez, María Manuela, et al.
Publicado: (2017)

Predictors of calcification distribution in severe tricuspid aortic valve stenosis
por: Piayda, Kerstin, et al.
Publicado: (2021)

Focusing on the Native Matrix Proteins in Calcific Aortic Valve Stenosis
por: Anousakis-Vlachochristou, Nikolaos, et al.
Publicado: (2023)

Association of serum lipoprotein(a) level with the severity and prognosis of calcific aortic valve stenosis: a Chinese cohort study
por: Liu, Shuo-Lin, et al.
Publicado: (2020)

PCSK9 and Calcific Aortic Valve Stenosis: Moving Beyond Lipids
por: Leopold, Jane A.
Publicado: (2020)

Aortic valve calcification is subject to aortic stenosis severity and the underlying flow pattern
por: Veulemans, Verena, et al.
Publicado: (2020)

Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis
por: Perrot, Nicolas, et al.
Publicado: (2020)

Lipoprotein(a) Induces Human Aortic Valve Interstitial Cell Calcification
por: Yu, Bin, et al.
Publicado: (2017)

Lipoprotein(a), a Lethal Player in Calcific Aortic Valve Disease
por: Hu, Jiahui, et al.
Publicado: (2022)

Calcific Aortic Stenosis
por: Wren, C., et al.
Publicado: (1983)

Lipoprotein Proteomics and Aortic Valve Transcriptomics Identify Biological Pathways Linking Lipoprotein(a) Levels to Aortic Stenosis
por: Bourgeois, Raphaëlle, et al.
Publicado: (2021)

Hutchinson–Gilford progeria syndrome with severe calcific aortic valve stenosis
por: Hanumanthappa, Natesh B, et al.
Publicado: (2011)

Cardiac Autonomic Response to Active Standing in Calcific Aortic Valve Stenosis
por: Torres-Arellano, José M., et al.
Publicado: (2021)

Circulating Irisin Level as a Biomarker for Pure Aortic Stenosis and Aortic Valve Calcification
por: Wang, Shan-shan, et al.
Publicado: (2022)

Aortic valve calcification in the era of non-coding RNAs: The revolution to come in aortic stenosis management?
por: Nader, Joseph, et al.
Publicado: (2020)

Current Evidence and Future Perspectives on Pharmacological Treatment of Calcific Aortic Valve Stenosis
por: Donato, Maristella, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lqrcbsdrig8i56tsov25sjbsro